[Federal Register Volume 69, Number 166 (Friday, August 27, 2004)]
[Notices]
[Pages 52735-52736]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-19595]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission will convene a meeting 
of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on 
October 13 and 14, 2004. A sample of agenda items to be discussed 
during the public sessions includes: (1) Use of I-125 Brachytherapy 
Seeds as Markers; (2) Proposed Changes to Abnormal Occurrence Criteria; 
(3) Discussion of Medical Event Criteria; and, (4) Update on St. Joseph 
Mercy Hospital Dose Reconstruction Case. To review the agenda, see 
http://www.nrc.gov/ reading-rm/doc-collections/acmui/schedules/2004/ or 
contact [email protected].

Purpose: Discuss issues related to 10 CFR Part 35, Medical Use of 
Byproduct Material.

Date and Time for Closed Session Meeting: October 13, 2004, from 8 a.m. 
to 10 a.m. This session will be closed so that NRC staff can give the 
ACMUI its required annual ethics briefing.

Dates and Times for Public Meetings: October 13, 2004, from 8:30 a.m. 
to 5 p.m.; October 14, 2004, from 8 a.m. to 5 p.m.

Address for Public Meetings: U.S. Nuclear Regulatory Commission, Two 
White Flint North Building, Room T2B3, 11545 Rockville Pike, Rockville, 
MD 20852-2738.

FOR FURTHER INFORMATION CONTACT: Angela R. McIntosh, telephone (301) 
415-5030; e-mail [email protected] of the Office of Nuclear Material Safety 
and Safeguards, U.S. Nuclear Regulatory Commission, Washington, DC 
20555-0001.

Conduct of the Meeting

    Leon S. Malmud, M.D., will chair the meeting. Dr. Malmud will 
conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:
    1. Persons who wish to provide a written statement should submit a

[[Page 52736]]

reproducible copy to Angela R. McIntosh, U.S. Nuclear Regulatory 
Commission, Two White Flint North, Mail Stop T8F5, 11545 Rockville 
Pike, Rockville, MD 20852-2738. Submittals must be postmarked by 
September 15, 2004, and must pertain to the topics on the agenda for 
the meeting.
    2. Questions from members of the public will be permitted during 
the meeting, at the discretion of the Chairman.
    3. The transcript and written comments will be available for 
inspection on NRC's Web site (http://www.nrc.gov) and at the NRC Public 
Document Room, 11555 Rockville Pike, Rockville, MD 20852-2738, 
telephone (800) 397-4209, on or about January 14, 2005. This meeting 
will be held in accordance with the Atomic Energy Act of 1954, as 
amended (primarily Section 161a); the Federal Advisory Committee Act (5 
U.S.C. App); and the Commission's regulations in Title 10, U.S. Code of 
Federal Regulations, Part 7.
    4. Attendees are requested to notify Angela R. McIntosh at (301) 
415-5030 of their planned attendance if special services, such as for 
the hearing impaired, are necessary.

    Dated at Rockville, Maryland, this 23rd day of August, 2004.

    For the Nuclear Regulatory Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 04-19595 Filed 8-26-04; 8:45 am]
BILLING CODE 7590-01-P